Charles Rhyee
Stock Analyst at TD Cowen
(0.82)
# 3,603
Out of 4,814 analysts
52
Total ratings
30.3%
Success rate
-14.93%
Average return
Main Sectors:
Stocks Rated by Charles Rhyee
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ICLR ICON Public Limited Company | Downgrades: Hold | $254 → $157 | $139.30 | +12.71% | 4 | Apr 14, 2025 | |
| MEDP Medpace Holdings | Downgrades: Hold | $370 → $328 | $296.28 | +10.71% | 4 | Apr 14, 2025 | |
| CAH Cardinal Health | Upgrades: Buy | $130 → $144 | $134.68 | +6.92% | 2 | Jan 8, 2025 | |
| CRL Charles River Laboratories International | Maintains: Hold | $203 → $227 | $105.93 | +114.29% | 5 | Nov 11, 2024 | |
| FTRE Fortrea Holdings | Maintains: Hold | $23 → $25 | $5.28 | +373.48% | 3 | Nov 11, 2024 | |
| TDOC Teladoc Health | Maintains: Hold | $9 → $8 | $6.83 | +17.13% | 6 | Oct 31, 2024 | |
| VEEV Veeva Systems | Maintains: Hold | $180 → $192 | $220.66 | -12.99% | 3 | Aug 29, 2024 | |
| GDRX GoodRx Holdings | Maintains: Buy | $14 → $16 | $4.48 | +257.54% | 7 | May 16, 2024 | |
| TALK Talkspace | Maintains: Outperform | $4 → $5 | $2.67 | +87.27% | 2 | May 3, 2023 | |
| AMWL American Well | Downgrades: Market Perform | $100 → $50 | $6.99 | +615.31% | 3 | Mar 23, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | $251 | $143.91 | +74.41% | 1 | Dec 6, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $70 → $56 | $3.17 | +1,666.56% | 2 | Oct 20, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $18 → $14 | $0.75 | +1,773.16% | 3 | Aug 16, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $48 → $50 | $8.97 | +457.41% | 2 | Jun 21, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $325 → $361 | $697.08 | -48.21% | 3 | Apr 18, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | $3,240 | $1.41 | +229,687.23% | 1 | Jul 16, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Market Perform | $35 | $19.45 | +79.95% | 1 | Feb 13, 2018 |
ICON Public Limited Company
Apr 14, 2025
Downgrades: Hold
Price Target: $254 → $157
Current: $139.30
Upside: +12.71%
Medpace Holdings
Apr 14, 2025
Downgrades: Hold
Price Target: $370 → $328
Current: $296.28
Upside: +10.71%
Cardinal Health
Jan 8, 2025
Upgrades: Buy
Price Target: $130 → $144
Current: $134.68
Upside: +6.92%
Charles River Laboratories International
Nov 11, 2024
Maintains: Hold
Price Target: $203 → $227
Current: $105.93
Upside: +114.29%
Fortrea Holdings
Nov 11, 2024
Maintains: Hold
Price Target: $23 → $25
Current: $5.28
Upside: +373.48%
Teladoc Health
Oct 31, 2024
Maintains: Hold
Price Target: $9 → $8
Current: $6.83
Upside: +17.13%
Veeva Systems
Aug 29, 2024
Maintains: Hold
Price Target: $180 → $192
Current: $220.66
Upside: -12.99%
GoodRx Holdings
May 16, 2024
Maintains: Buy
Price Target: $14 → $16
Current: $4.48
Upside: +257.54%
Talkspace
May 3, 2023
Maintains: Outperform
Price Target: $4 → $5
Current: $2.67
Upside: +87.27%
American Well
Mar 23, 2023
Downgrades: Market Perform
Price Target: $100 → $50
Current: $6.99
Upside: +615.31%
Dec 6, 2022
Initiates: Outperform
Price Target: $251
Current: $143.91
Upside: +74.41%
Oct 20, 2022
Maintains: Outperform
Price Target: $70 → $56
Current: $3.17
Upside: +1,666.56%
Aug 16, 2022
Maintains: Outperform
Price Target: $18 → $14
Current: $0.75
Upside: +1,773.16%
Jun 21, 2022
Maintains: Outperform
Price Target: $48 → $50
Current: $8.97
Upside: +457.41%
Apr 18, 2022
Maintains: Outperform
Price Target: $325 → $361
Current: $697.08
Upside: -48.21%
Jul 16, 2020
Initiates: Outperform
Price Target: $3,240
Current: $1.41
Upside: +229,687.23%
Feb 13, 2018
Initiates: Market Perform
Price Target: $35
Current: $19.45
Upside: +79.95%